+关注
韩奕
暂无个人介绍
IP属地：浙江
23
关注
1
粉丝
0
主题
0
勋章
主贴
热门
韩奕
2023-09-06
$Faraday Future(FFIE)$
韩奕
2023-09-05
$Faraday Future(FFIE)$
韩奕
2023-08-29
$Faraday Future(FFIE)$
韩奕
2023-04-06
$Faraday Future(FFIE)$
韩奕
2021-04-29
不要脸
抱歉，原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3457927798259849","uuid":"3457927798259849","gmtCreate":1591973544488,"gmtModify":1591973544488,"name":"韩奕","pinyin":"hyhanyi","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":23,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":216782435229864,"gmtCreate":1693958853951,"gmtModify":1693958854754,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/216782435229864","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":216604178641016,"gmtCreate":1693915350612,"gmtModify":1693916922600,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/216604178641016","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":214095213281536,"gmtCreate":1693287485211,"gmtModify":1693287620680,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/214095213281536","isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":653859331,"gmtCreate":1680767364623,"gmtModify":1680768496894,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/653859331","isVote":1,"tweetType":1,"viewCount":20,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109306284,"gmtCreate":1619662177148,"gmtModify":1619662460716,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"不要脸","listText":"不要脸","text":"不要脸","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/109306284","repostId":"2131306590","repostType":2,"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":216782435229864,"gmtCreate":1693958853951,"gmtModify":1693958854754,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/216782435229864","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":216604178641016,"gmtCreate":1693915350612,"gmtModify":1693916922600,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/216604178641016","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":214095213281536,"gmtCreate":1693287485211,"gmtModify":1693287620680,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/214095213281536","isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":653859331,"gmtCreate":1680767364623,"gmtModify":1680768496894,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"0\"></v-v>","text":"$Faraday Future(FFIE)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/653859331","isVote":1,"tweetType":1,"viewCount":20,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109306284,"gmtCreate":1619662177148,"gmtModify":1619662460716,"author":{"id":"3457927798259849","authorId":"3457927798259849","name":"韩奕","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3457927798259849","authorIdStr":"3457927798259849"},"themes":[],"htmlText":"不要脸","listText":"不要脸","text":"不要脸","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/109306284","repostId":"2131306590","repostType":2,"repost":{"id":"2131306590","kind":"news","pubTimestamp":1619649878,"share":"https://www.laohu8.com/m/news/2131306590?lang=&edition=full","pubTime":"2021-04-29 06:44","market":"hk","language":"zh","title":"兆科眼科(06622)公布全球发售结果：最终定价为每股16.80港元，将于4月29日在港主板开始交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2131306590","media":"智通财经","summary":"致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司，今日公布最后发售股份定价及全球股份发售结果。股份将于2021年4月29日(周四)上午9点于香港联合交易所有限公司主板进行买卖，股份代号为06622。公开发售初步提呈的发售股份已获适度超额认购，相当于可供认购的公开发售股份总数12,357,000股的约56倍以上。兆科眼科每股最终发售股份定价为16.80港元，公司预计将从全球发售获得的所得款项净额约为1,941.6百万港元。","content":"<html><body><p>致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(06622)，今日公布最后发售股份定价及全球股份发售结果。股份将于2021年4月29日(周四)上午9点于香港联合交易所有限公司主板进行买卖，股份代号为06622。每手股数为500股。</p><p>公开发售初步提呈的发售股份已获适度超额认购，相当于可供认购的公开发售股份总数12,357,000股的约56倍以上。而国际配售初步提呈的发售股份亦已获适度超额认购，相当于国际配售初步可供认购之111,210,500股的约5.3倍以上。同时，根据公司与“基石投资者”订立的基石投资协议，基石投资者已认购25,461,000股股份，占全球发售的发售股份数目的约20.60%(假设超额配售权未获行使)。有关基石投资者的进一步详情，请参阅招股章程“基石投资者”一节。</p><p>兆科眼科每股最终发售股份定价为16.80港元，公司预计将从全球发售获得的所得款项净额约为1,941.6百万港元(经扣除包销佣金及本公司已付或应付的其他上市相关开支后，且于任何超额配售权获行使前)。集资所得主要用于核心产品的临床开发及商业化、为其他在研候选药物的持续研发活动及商业化提供资金、对位于南沙的先进生产设施进行生产线扩张，为业务开发活动及在研药物的拓展提供资金等。</p><p><a href=\"https://laohu8.com/S/GS\">高盛</a>(亚洲)有限责任公司、富瑞金融集团香港有限公司为联席保荐人、联席代表、联席全球协调人、联席账簿管理人及联席牵头经办人。</p><p>兆科眼科董事会主席、执行董事兼行政总裁李小羿博士表示：“我们十分感谢各界投资者对兆科眼科的支持与关注。集团于香港公开发售与配售均获得超额认购，反映出投资者对生物制药行业发展空间的充分肯定，以及对公司前景充满信心。兆科眼科本次成功上市，不仅意味着公司发展迈入新篇章，更为公司长远发展奠下深厚基础。未来，我们将持续深耕眼科制药行业，紧抓市场发展机遇，提升公司核心竞争力的同时充分利用国际资本环境，向成为中国及邻近的东盟市场领导者这一目标迈进，为股东创造最大的价值。”</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>兆科眼科(06622)公布全球发售结果：最终定价为每股16.80港元，将于4月29日在港主板开始交易</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n兆科眼科(06622)公布全球发售结果：最终定价为每股16.80港元，将于4月29日在港主板开始交易\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-29 06:44 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/463236.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(06622)，今日公布最后发售股份定价及全球股份发售结果。股份将于2021年4月29日(周四)上午9点于香港联合交易所有限公司主板进行买卖，股份代号为06622。每手股数为500股。公开发售初步提呈的发售股份已获适度超额认购，相当于可供认购的公开发售股份总数12,357,000股的约56倍以上。而国际配售初步提呈的发售股份亦已获...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/463236.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://www.zhitongcaijing.com/content/detail/463236.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2131306590","content_text":"致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(06622)，今日公布最后发售股份定价及全球股份发售结果。股份将于2021年4月29日(周四)上午9点于香港联合交易所有限公司主板进行买卖，股份代号为06622。每手股数为500股。公开发售初步提呈的发售股份已获适度超额认购，相当于可供认购的公开发售股份总数12,357,000股的约56倍以上。而国际配售初步提呈的发售股份亦已获适度超额认购，相当于国际配售初步可供认购之111,210,500股的约5.3倍以上。同时，根据公司与“基石投资者”订立的基石投资协议，基石投资者已认购25,461,000股股份，占全球发售的发售股份数目的约20.60%(假设超额配售权未获行使)。有关基石投资者的进一步详情，请参阅招股章程“基石投资者”一节。兆科眼科每股最终发售股份定价为16.80港元，公司预计将从全球发售获得的所得款项净额约为1,941.6百万港元(经扣除包销佣金及本公司已付或应付的其他上市相关开支后，且于任何超额配售权获行使前)。集资所得主要用于核心产品的临床开发及商业化、为其他在研候选药物的持续研发活动及商业化提供资金、对位于南沙的先进生产设施进行生产线扩张，为业务开发活动及在研药物的拓展提供资金等。高盛(亚洲)有限责任公司、富瑞金融集团香港有限公司为联席保荐人、联席代表、联席全球协调人、联席账簿管理人及联席牵头经办人。兆科眼科董事会主席、执行董事兼行政总裁李小羿博士表示：“我们十分感谢各界投资者对兆科眼科的支持与关注。集团于香港公开发售与配售均获得超额认购，反映出投资者对生物制药行业发展空间的充分肯定，以及对公司前景充满信心。兆科眼科本次成功上市，不仅意味着公司发展迈入新篇章，更为公司长远发展奠下深厚基础。未来，我们将持续深耕眼科制药行业，紧抓市场发展机遇，提升公司核心竞争力的同时充分利用国际资本环境，向成为中国及邻近的东盟市场领导者这一目标迈进，为股东创造最大的价值。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
